IN B005
Alternative Names: IN-B00002; IN-B005; TANKIOLatest Information Update: 07 Jan 2025
At a glance
- Originator CJ Cheiljedang Corp.
- Class Antineoplastics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cancer
Highest Development Phases
- Research Cancer